MARKET OUTLOOK
The publisher's report alludes that the North American amniotic membrane market is assessed to attain a CAGR of 6.82% over the forecasting years 2022 to 2028. The United States and Canada form the market in the given region.
In Canada, an amniotic membrane has been used in treating wounds and burns. Since the amniotic membrane is rich in collagen, it has been useful in healing wounds effectively and reducing scars. Moreover, it has antibacterial properties, reducing pain significantly. The revival of amniotic membrane use in various treatments, including wound management, has occurred following the introduction of advanced techniques. In this regard, several techniques have been formed to desiccate the material while upholding several wound-healing attributes to produce a temperature-stable allograft. Therefore, such factors support the amniotic membrane market’s growth.
As per the US National Library of Medicine, the application of amniotic membrane has shown promising results in treating ocular surface disorders. Amniotic membrane transplantation has emerged as a key component of ocular surface reconstructions. Besides this, it has been used in treating limbal stem cell deficiency (LSCD) to protect limbal stem cells. Amniotic membrane use in burn injuries is also witnessed in the country. Such developments are expected to boost the amniotic membrane market on a progressive path.
COMPETITIVE OUTLOOK
The major companies in the amniotic membrane market consist of Labtician Ophthalmics Inc, Human Regenerative Technologies, Organogenesis, and Sky Biologics LLC.
Table of Contents
1. North America Amniotic Membrane Market - Summary
2. Industry Outlook
3. North America Amniotic Membrane Market Outlook - by Type
4. North America Amniotic Membrane Market Outlook - by Application
5. North America Amniotic Membrane Market Outlook - by End-Users
6. North America Amniotic Membrane Market – Regional Outlook
7. Competitive Landscape
8. Research Methodology & Scope
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Amino Technology LLC
- Katena Products Inc
- Mimedx
- Bio Tissue Inc
- Surgilogix LLC
- Amniox Medical Inc
- Surgenix LLC
- Labtician Ophthalmics Inc
- Human Regenerative Technologies
- Integra Lifescience Corp
- Smith and Nephew plc
- Organogenesis
- Celularity Inc
- Sky Biologics LLC